The JPML (courts) decided to make two separate litigations because the injuries involved will require different medical evidence, experts, and causation theories
Research has shown that semaglutide can reduce the risk of death from non-fatal heart attack or stroke by about 20%
Wegovy, an FDA-approved injectable, is a brand name for semaglutide
Large registry-based studies found no increased risk for ileus, intestinal obstruction, pancreatitis, gallbladder disease, or other serious adverse events among patients with IBD receiving GLP-1 RAs
What happens as my delivery time nears
Serious hypersensitivity reactions including anaphylaxis and angioedema have been reported with semaglutide tablets [see Warnings and Precautions (5.7)]